A recent study by Rosa et al. examined the association between brain-derived neurotrophic factor (BDNF), a neuroprotective mediator, and cognitive impairment in primary APS, with lower levels of BDNF associated with cognitive impairment in these patients [47]. The gene discussed is BDNF; the disease is Cognitive impairment.